Insights

Gathering insights about DMR…

Similar companies to DMR

DMR Tech Stack

DMR uses 8 technology products and services including html5media, Webpack, Cloudflare DNS, and more. Explore DMR's tech stack below.

html5media
Audio, Video, Graphics
Webpack
Development
Cloudflare DNS
Domain Name Services
Sentry
Issue Trackers
JSON-LD
Javascript Frameworks
Lodash
Javascript Libraries
WebsiteBuilder
Page Builders
Bootstrap
UI Frameworks

Media & News

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it granted equity awards to nine newly-hired, non-executive employees on July 1, 2026. The inducement grants were approved by Damora's independent Compensation Committee of its Board of Directors and were made as material inducements to such individuals' acceptance of employment with Damora in accordance with Nasdaq Listing Rule 5635(c)(4).
Jul 01, 2026 | www.globenewswire.com
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, June 01, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it granted equity awards to six newly-hired, non-executive employees on June 1, 2026. The inducement grants were approved by Damora's independent Compensation Committee of its Board of Directors and were made as material inducements to such individuals' acceptance of employment with Damora in accordance with Nasdaq Listing Rule 5635(c)(4).
Jun 01, 2026 | www.globenewswire.com
Damora Therapeutics: Well-Funded Moonshot For CALR Mutations
Damora Therapeutics is focused on mutant-CALR blood diseases, with DMR-001 as its lead asset. They have approximately $562.3 million in cash, and management believes this gives them enough runway into 2029. DMRA's lead asset has potential competitors in more advanced R&D stages. This helps validate the asset class as a whole, but DMRA still needs more data of its own.
May 27, 2026 | seekingalpha.com
Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
– DMR-001 preclinical data showcasing potentially best-in-class potency, half-life and anti-mutCALR activity to be presented at 2026 European Hematology Association Congress – – On track to submit first regulatory submissions to enable clinical development for DMR-001, an Fc-null anti-mutCALR antibody, and DMR-002, an Fc-enhanced anti-mutCALR antibody, in mid-2026 and second-half 2026, respectively – – Appointed CEO and key leadership team members to accelerate vision of redefining care for patients with mutCALR-driven myeloproliferative neoplasms – – Strong financial position with approximately $533 million in cash and cash equivalents as of March 31, 2026, expected to fund operations into 2029 – BOSTON, May 12, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (“Damora” or the “Company”) (NASDAQ: DMRA), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced its operating and financial results for the quarter ended March 31, 2026, and recent corporate highlights. “We are pleased with our meaningful progress in advancing our mutant calreticulin (mutCALR)-targeted therapy pipeline, including three highly differentiated assets with distinct mechanisms that uniquely position Damora to drive innovation across all forms of mutCALR-driven disease,” said Jennifer Jarrett, President and Chief Executive Officer of Damora Therapeutics.
May 12, 2026 | www.globenewswire.com
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it granted equity awards to two newly-hired, non-executive employees. The inducement grants were approved by Damora's independent Compensation Committee and were made as material inducements to such individuals' acceptance of employment with Damora in accordance with Nasdaq Listing Rule 5635(c)(4).
May 01, 2026 | www.globenewswire.com
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Given Consensus Recommendation of “Moderate Buy” by Analysts
Shares of Damora Therapeutics, Inc. Common Stock (NASDAQ: DMRA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the seven analysts that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, three have assigned a buy recommendation
Apr 23, 2026 | www.defenseworld.net
What Makes Galecto, Inc. (DMRA) a Strong Momentum Stock: Buy Now?
Does Galecto, Inc. (DMRA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Apr 20, 2026 | www.zacks.com

DMR's Email Address Formats

DMR uses at least 2 format(s):

DMR Email Formats	Example	Percentage
FirstLast@dmrevents.com	JohnDoe@dmrevents.com	83%
First.Last@dmrevents.com	John.Doe@dmrevents.com	9%
First@dmrevents.com	John@dmrevents.com	4%
FirstL@dmrevents.com	JohnD@dmrevents.com	4%
First@dmrstl.com	John@dmrstl.com	100%

Frequently Asked Questions

Where is DMR's headquarters located?

DMR's main headquarters is located at 2200 Gravois Avenue St. Louis, Missouri 63104 United States. The company has employees across 1 continents, including North America.

What is DMR's phone number?

You can contact DMR's main corporate office by phone at

+1-800-611-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is DMR's stock symbol?

DMR is a publicly traded company; the company's stock symbol is DMRA.

What is DMR's official website and social media links?

DMR's official website is dmrstl.com and has social profiles on LinkedIn.

What is DMR's NAICS code?

DMR's NAICS code is 7211 - Traveler Accommodation.

How many employees does DMR have currently?

As of June 2026, DMR has approximately 58 employees across 1 continents, including North America. Key team members include Chief Technology Officer: C. J.President And Ceo: N. R.President: C. D.. Explore DMR's employee directory with LeadIQ.

What industry does DMR belong to?

DMR operates in the Hospitality industry.

What technology does DMR use?

DMR's tech stack includes html5mediaWebpackCloudflare DNSSentryJSON-LDLodashWebsiteBuilderBootstrap.

What is DMR's email format?

DMR's email format typically follows the pattern of FirstLast@dmrevents.com. Find more DMR email formats with LeadIQ.

When was DMR founded?

DMR was founded in 1987.

DMR

Q: What is DMR's official website and social media links?

DMR's official website is dmrstl.com. DMR has social profiles on LinkedIn.

Q: How many employees does DMR have currently?

DMR has approximately 58 employees.

Q: What technology does DMR use?

DMR's tech stack includes Open Graph, Cloudflare DNS, html5media, Microsoft 365, Webpack.

Q: What is DMR's NAICS code?

DMR's NAICS code is 7211 (Traveler Accommodation).

HospitalityMissouri, United States51-200 Employees

DMRStL provides professional temporary staffing for the hospitality industry, initially focusing on Front of House roles and expanding to Culinary Back of the House positions and professional chefs. The company serves the St. Louis Metropolitan Area, working with a large share of local food service management companies and a broad base of corporate accounts. It is recognized as a supplier of qualified hospitality talent in the region. 

Founded in 1987 as DMR Events, Inc., the business evolved to include a wider range of hospitality staffing needs over time. In 2015, ownership transitioned to private family ownership, with Douglas M. Risch serving as Principal Partner across the Risch companies.